BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2717402)

  • 1. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific.
    Bocquel MT; Kumar V; Stricker C; Chambon P; Gronemeyer H
    Nucleic Acids Res; 1989 Apr; 17(7):2581-95. PubMed ID: 2717402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptors compete for factors that mediate their enhancer function.
    Meyer ME; Gronemeyer H; Turcotte B; Bocquel MT; Tasset D; Chambon P
    Cell; 1989 May; 57(3):433-42. PubMed ID: 2720778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of steroid regulation of the MMTV promoter in a small cell lung cancer cell line is caused by a DNA sequence flanking the glucocorticoid response element.
    Huynh TT; Ray DW; Brogan IJ; Stevens A; Davis JR; White A; White A
    J Endocrinol; 2002 Feb; 172(2):295-302. PubMed ID: 11834447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.
    Le Ricousse S; Gouilleux F; Fortin D; Joulin V; Richard-Foy H
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5072-7. PubMed ID: 8643531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
    Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
    Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
    Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of hybrid response elements with wild-type and mutant steroid hormone receptors.
    Truss M; Chalepakis G; Slater EP; Mader S; Beato M
    Mol Cell Biol; 1991 Jun; 11(6):3247-58. PubMed ID: 2038329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
    Uht RM; Anderson CM; Webb P; Kushner PJ
    Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
    Whitacre DC; Karnas KJ; Miesfeld RL
    Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
    Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
    Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors.
    Kraus WL; Weis KE; Katzenellenbogen BS
    Mol Cell Biol; 1995 Apr; 15(4):1847-57. PubMed ID: 7891678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.
    Maroder M; Farina AR; Vacca A; Felli MP; Meco D; Screpanti I; Frati L; Gulino A
    Mol Endocrinol; 1993 Apr; 7(4):570-84. PubMed ID: 8388998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
    Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
    EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells.
    Chapman MS; Askew DJ; Kuscuoglu U; Miesfeld RL
    Mol Endocrinol; 1996 Aug; 10(8):967-78. PubMed ID: 8843413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic disruption of steroid receptor gene activation: Complex dose-response effects are shared by several steroid receptors.
    Bodwell JE; Gosse JA; Nomikos AP; Hamilton JW
    Chem Res Toxicol; 2006 Dec; 19(12):1619-29. PubMed ID: 17173375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.